Description | Setmelanotide Acetate(920014-72-8 free base) (RM-493 Acetate) is a selective agonist of melanocortin 4 receptor (MC4R)(human and rat MC4R with EC50s of 0.27 nM and 0.28 nM, respectively). |
In vitro | 黑色素皮质素受体激动剂在大脑中调节食物摄入和体重,并且与这些作用独立,影响胰岛素敏感性。Setmelanotide 对人类和大鼠MC4R(人类和大鼠MC4R的Kis分别为2.1和2.7 nM,EC50s分别为0.27和0.28 nM)表现出激动剂活性[1]。 |
In vivo | BIM-22493在夜间禁食后抑制再进食的效果依赖于功能性MC4R。BIM-22493能迅速改善葡萄糖稳态。在Lepob/Lepob小鼠中,BIM-22493显著增强葡萄糖清除效率,相较对照组。长期治疗BIM-22493与显著降低的血清胰岛素水平、血糖以及HOMA-IR值相关,这表明提高了胰岛素敏感性[1]。setmelanotide治疗能引起食物摄入短暂减少(35%),并在8周治疗期间可持续减重(13.5%),该数据来自一项饮食诱导的肥胖非人灵长类动物模型的研究[2]。 |
Target activity | MC4R (rat): 2.7 nM (ki), MC4R (rat):0.28 Nm (EC50), MC5R (human): 1600 nM (EC50), MC5R (human): 430 nM (ki), MC3R (human): 10 nM (ki), MC3R (human): 5.3nM (EC50), MC4R (human): 0.27 nM (EC50), MC4R (human): 2.1 nM (ki), MC1R (human):3.9 nM (ki), MC1R (human):5.8 nM (EC50) |
Synonyms | RM-493 Acetate, IRC-022493 Acetate, BIM-22493 Acetate |
molecular weight | 1177.35 |
Molecular formula | C51H72N18O11S2 |
CAS | 2759937-80-7 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Solubility | DMSO: 22.5 mg/mL (19.11 mM) |
References | 1. Kumar KG, et al. Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice. Peptides. 2009 Oct;30(10):1892-900. 2. Kievit P, et al. Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes. 2013 Feb;62(2):490-7. |